These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28413936)

  • 21. Changes in event-related potentials with stimulant medication in children with attention deficit hyperactivity disorder.
    Taylor MJ; Voros JG; Logan WJ; Malone MA
    Biol Psychol; 1993 Sep; 36(3):139-56. PubMed ID: 8260563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD.
    Hammerness P; Fried R; Petty C; Meller B; Biederman J
    Child Neuropsychol; 2014; 20(3):319-27. PubMed ID: 23639146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of methylphenidate on spatial attention asymmetry in adolescents with attention deficit hyperactivity disorder (ADHD): preliminary findings.
    Silk TJ; Newman DP; Eramudugolla R; Vance A; Bellgrove MA
    Neuropsychologia; 2014 Apr; 56():178-83. PubMed ID: 24486422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate effects of methylphenidate on cognitive attention skills of children with attention-deficit-hyperactivity disorder.
    Hood J; Baird G; Rankin PM; Isaacs E
    Dev Med Child Neurol; 2005 Jun; 47(6):408-14. PubMed ID: 15934489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder.
    Turner DC; Blackwell AD; Dowson JH; McLean A; Sahakian BJ
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):286-95. PubMed ID: 15338103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylphenidate, interstimulus interval, and reaction time performance of children with attention deficit/hyperactivity disorder: a pilot study.
    van der Meere JJ; Shalev RS; Borger N; Wiersema JR
    Child Neuropsychol; 2009 Nov; 15(6):554-66. PubMed ID: 19296298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
    Fredriksen M; Dahl AA; Martinsen EW; Klungsøyr O; Haavik J; Peleikis DE
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1873-84. PubMed ID: 25453480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Task demands interact with the single and combined effects of medication and contingencies on children with ADHD.
    Tamm L; Carlson CL
    J Atten Disord; 2007 May; 10(4):372-80. PubMed ID: 17449836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial.
    Whyte J; Hart T; Vaccaro M; Grieb-Neff P; Risser A; Polansky M; Coslett HB
    Am J Phys Med Rehabil; 2004 Jun; 83(6):401-20. PubMed ID: 15166683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covert visual spatial attention in boys with attention deficit hyperactivity disorder: lateral effects, methylphenidate response and results for parents.
    Nigg JT; Swanson JM; Hinshaw SP
    Neuropsychologia; 1997 Feb; 35(2):165-76. PubMed ID: 9025120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.
    Biederman J; Seidman LJ; Petty CR; Fried R; Doyle AE; Cohen DR; Kenealy DC; Faraone SV
    J Clin Psychiatry; 2008 Jul; 69(7):1150-6. PubMed ID: 18517288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylphenidate-induced improvements of various measures of attention in adults with attention deficit hyperactivity disorder.
    Tucha O; Mecklinger L; Laufkötter R; Klein HE; Walitza S; Lange KW
    J Neural Transm (Vienna); 2006 Oct; 113(10):1575-92. PubMed ID: 16897610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
    Ince Tasdelen B; Karakaya E; Oztop DB
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Attention-Deficit/Hyperactivity Disorder and Methylphenidate Treatment on the Adult Auditory Temporal Order Judgment Threshold.
    Fostick L
    J Speech Lang Hear Res; 2017 Jul; 60(7):2124-2128. PubMed ID: 28672285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
    Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
    Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of methylphenidate on complex cognitive processing in attention-deficit hyperactivity disorder.
    Berman T; Douglas VI; Barr RG
    J Abnorm Psychol; 1999 Feb; 108(1):90-105. PubMed ID: 10066996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylphenidate improves some but not all measures of attention, as measured by the TEA-Ch in medication-naïve children with ADHD.
    Paton K; Hammond P; Barry E; Fitzgerald M; McNicholas F; Kirley A; Robertson IH; Bellgrove MA; Gill M; Johnson KA
    Child Neuropsychol; 2014; 20(3):303-18. PubMed ID: 23639119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atomoxetine could improve intra-individual variability in drug-naïve adults with attention-deficit/hyperactivity disorder comparably with methylphenidate: A head-to-head randomized clinical trial.
    Ni HC; Hwang Gu SL; Lin HY; Lin YJ; Yang LK; Huang HC; Gau SS
    J Psychopharmacol; 2016 May; 30(5):459-67. PubMed ID: 26905919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.